Zalicus
SITE MAP   |   CAREERS   |   CONTACT   |   
Company Overview

Zalicus is a biopharmaceutical company focused on discovering and developing novel-target pain therapies. Zalicus has a portfolio of proprietary product candidates targeting pain, including Z944, a T-type calcium channel modulator for chronic and acute pain, and modulators of the NaV 1.7 channel for chronic or acute pain. We have entered into multiple revenue-generating collaborations with large pharmaceutical companies relating to other products, product candidates and drug discovery technologies. Zalicus applies its expertise in the discovery and development of selective ion channel modulators and its combination high throughput screening capabilities to discover innovative therapeutics for itself and its collaborators in the areas of pain, oncology and infectious disease.

 

Zalicus Leadership

Zalicus Leadership

 

Collaborators

 

Zalicus Collaborators